13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
The more things change, the more things stay the same. As compliance matures as an industry, we some...
Read More >
On November 14, 2019, the Oregon Court of Appeals in Maza v. Waterford Operations, LLC, 300 Or. App....
Read More >
Most employers are well aware that employees must be paid on a “salary basis” to be considered exe...
Read More >
We next consider how to create a more effective compliance program involving business ventures. This...
Read More >
One Equity Partners has announced it acquired American Medical Technologies. American Medical Techn...
Read More >
The Further Consolidated Appropriations Act, 2020 (the “Act”), enacted on December 20, 2019, signi...
Read More >